Pharmacotherapy for Breakthrough Cancer Pain

被引:0
|
作者
Sebastiano Mercadante
机构
[1] La Maddalena Cancer Center,Pain Relief and Palliative Care Unit
[2] University of Palermo,Palliative Medicine, Department of Anesthesia and Intensive Care
来源
Drugs | 2012年 / 72卷
关键词
Fentanyl; Oxycodone; Oral Morphine; Oral Transmucosal Fentanyl Citrate; Fentanyl Buccal Tablet;
D O I
暂无
中图分类号
学科分类号
摘要
Breakthrough pain (BTP) is a transient exacerbation of pain that occurs either spontaneously, or in relation to a specific predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain.
引用
收藏
页码:181 / 190
页数:9
相关论文
共 50 条
  • [41] COSTS ASSOCIATED WITH BREAKTHROUGH PAIN IN CANCER PATIENTS: FINDINGS FROM THE NATIONAL BREAKTHROUGH PAIN SURVEY
    Narayana, A.
    Katz, N.
    Shillington, A. C.
    Stephenson, J. J.
    Frye, C.
    Portenoy, R.
    VALUE IN HEALTH, 2013, 16 (03) : A114 - A115
  • [42] Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain
    Sperlinga, R.
    Campagna, S.
    Berruti, A.
    Laciura, P.
    Ginosa, I.
    Paoletti, S.
    Giuliano, P. L.
    Tucci, M.
    Rosato, R.
    Scagliotti, G. V.
    Saini, A.
    EUROPEAN JOURNAL OF PAIN, 2015, 19 (07) : 881 - 888
  • [43] Cancer pain management - Basic therapy and treatment of breakthrough pain
    Nauck, F.
    SCHMERZ, 2007, 21 (04): : 359 - 370
  • [44] Cancer pain management - Basic therapy and treatment of breakthrough pain
    Nauck, F.
    Eulitz, N.
    ONKOLOGE, 2007, 13 (09): : 865 - 876
  • [45] Breakthrough cancer pain and rational drug use
    Nunez Olarte, Juan Manuel
    SUPPORTIVE CARE IN CANCER, 2017, 25 : 11 - 17
  • [46] Breakthrough pain in cancer patients: Pathophysiology and treatment
    Mercadante, S
    Arcuri, E
    CANCER TREATMENT REVIEWS, 1998, 24 (06) : 425 - 432
  • [47] A new transmucosal fentanyl for breakthrough cancer pain
    Rospond, RM
    CANCER PRACTICE, 1999, 7 (06) : 317 - 320
  • [48] Breakthrough cancer pain - Epidemiology, characteristics and management
    Fine, PG
    CNS DRUGS, 2000, 13 (05) : 313 - 319
  • [49] Breakthrough cancer pain and rational drug use
    Juan Manuel Núñez Olarte
    Supportive Care in Cancer, 2017, 25 : 11 - 17
  • [50] PHARMACOECONOMIC CONSIDERATIONS ABOUT BREAKTHROUGH CANCER PAIN
    Vellucci, R.
    Mediati, R. D.
    Gasperoni, S.
    Piergallini, L. M.
    Valentino, M. C.
    Bruno, G. M.
    Di Matteo, S.
    Colombo, G. L.
    VALUE IN HEALTH, 2015, 18 (07) : A665 - A666